Every week, there are so many important and interesting articles related to the care of women. While these articles may not fall under the umbrella of reproductive psychiatry, much of this information affects the women we care for.
The FDA accepted a New Drug Application for fezolinetant, a novel, nonhormonal selective neurokinin-3 receptor (NK3R) antagonist for the treatment of menopause-related vasomotor symptoms.
Despite the unequivocal benefits of folic acid supplementation and recommendations urging all women of reproductive age to take folic acid supplements, preconceptual use of folic acid has not increased substantially.
Every week we review the most recent publications in women’s mental health.
Although a small sample, no major malformations were observed in a prospectively followed cohort of women with first trimester exposure to buspirone.
The transition to menopause, or perimenopause, represents the passage from reproductive to non-reproductive life. During the perimenopause, women experience irregular menstrual cycles, which reflect the large fluctuations in ovarian hormone [...]
Every week, there are so many important and interesting articles related to the care of women. While these articles may not fall under the umbrella of reproductive psychiatry, much of this information affects the women we care for.
Family history of psychiatric illness, especially bipolar disorder, was associated with a signifiant increase in risk for postpartum depression.
Every week we review the most recent publications in women’s mental health.
Fathers may also suffer from perinatal depression and paternal depression, just like maternal depression, can have negative effects.
